驗證網址www.nejm.org安全性

FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer — NEJM

Original Article FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer Thierry Conroy, M.D., Françoise Desseigne, M.D., Marc Ychou, M.D., Ph.D., Olivier Bouché, M.D., Ph.D., Rosine Guimbaud, M.D., Ph.D., Yves Bécouarn, M.D., Antoine Adenis, M ......

網址安全性掃描由 google 提供